Crista Galli Ventures

Crista Galli Ventures is a Copenhagen-based venture capital firm established in 2020, specializing in early-stage healthtech companies. The firm primarily targets Seed and Series A rounds, demonstrating a clear commitment to fostering innovation within the digital health and biotech sectors. With a strategic focus on both European and US markets, Crista Galli Ventures positions itself as a key financial partner for nascent companies aiming to revolutionize healthcare.

The firm's investment strategy is centered on becoming either the first institutional investor or a co-lead in funding rounds. This hands-on approach suggests a desire to actively shape the growth trajectory of its portfolio companies from an early stage. Crista Galli Ventures typically deploys capital ranging from €500,000 to €3 million, with a stated sweet spot for investments between €1 million and €2 million. This flexibility allows them to support a diverse range of early-stage ventures, from those just beginning to scale to those ready for more significant growth.

Since its inception, Crista Galli Ventures has rapidly built a significant portfolio, having made 24 investments to date, according to Crunchbase. This active investment pace underscores their commitment to identifying and backing promising healthtech innovations. While the firm is still relatively young, its strategic focus and consistent investment activity indicate a long-term vision for impacting the global health landscape. Their dedication to supporting companies that leverage technology to improve health outcomes positions them as a notable player in the venture capital ecosystem for healthtech.